← SynDRA
HT-2157
SynDRA canonical compound SYN1951439 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | GALR3 |
| Mechanism of action | galanin receptor 3 antagonist |
All known targets
- GALR1; GALR2; GALR3
- GALR3
Mechanisms of action (all sources)
- galanin receptor 3 antagonist
- Antagonist
Cross-references
Synonyms
- HT 2157
- SNAP-37889
- UNII-WW4KZW83BX
- WW4KZW83BX
- CHEMBL210288
- 1-phenyl-3-[[3-(trifluoromethyl)phenyl]imino]-1h-indol-2-one
- 1-phenyl-3-[3-(trifluoromethyl)phenyl]iminoindol-2-one
- 1-Phenyl-3-((3-(trifluoromethyl)phenyl)imino)-1H-indol-2-one
- SNAP37889
- AC1LSUW9
- UNII-J4DRJ9BFS1
- UNII-EH5R4IAX6Q
- J4DRJ9BFS1
- EH5R4IAX6Q
- Bionet1_002696
- SCHEMBL916990
- SCHEMBL8273294
- GTPL6126
- HMS576C18
- MolPort-002-854-320
- BDBM50187923
- ZINC100301780
- AKOS005078094
- SNAP-37889, (E)-
- CS-6094
- HT-2157(SNAP37889)
Look up HT-2157 in the interactive SynDRA portal →